Antioxidants Attenuate Oxidative Stress-Induced Hidden Blood Loss in Rats
Journal Title: Turkish Journal of Hematology - Year 2017, Vol 34, Issue 4
Abstract
Objective: Hidden blood loss (HBL), commonly seen after total knee or hip arthroplasty, causes postoperative anemia even after reinfusion or blood transfusion based on the visible blood loss volume. Recent studies demonstrated that oxidative stress might be involved in HBL. However, whether the antioxidants proanthocyanidin (PA) or hydrogen water (HW) can ameliorate HBL remains poorly understood. The aim of this study was to evaluate the effects of PA and HW on HBL. Materials and Methods: A rat HBL model was established through administration of linoleic acid with or without treatment with PA or HW. The levels of hemoglobin (Hb), red blood cell (RBC) count, superoxide dismutase (SOD) activity, glutathione peroxidase (GSH-PX) activity, malondialdehyde (MDA), and ferryl Hb were measured. Results: RBC and Hb values as well as the activity of SOD and GSH-PX were reduced after administration of linoleic acid, which was ameliorated by treatment with PA or HW. In addition, the quantity of MDA was significantly decreased with the administration of PA or HW. Conclusion: PA and HW could ameliorate HBL in a rat model by reducing oxidative stress, suggesting that they might be used as a novel therapeutic approach in the prophylaxis or treatment of HBL in clinics.
Authors and Affiliations
Hong Qian, Tao Yuan, Jian Tong, Wen-shuang Sun, Jiajia Jin, Wen-xiang Chen, Jia Meng, Nirong Bao, Jianning Zhao
Keywords
Related Articles
- EP ID EP240037
- DOI 10.4274/tjh.2016.0469
- Views 92
- Downloads 0
Hindistan’da Beta Thalassemia Taşıyıcı Araştırması
Talasemi Taşıyıcılığı Olan Bir Hastada Parvovirüs B19 ve Herpes Virüs Enfeksiyonu ile Tetiklenen Herediter Sferositozun Başlangıç Tablosu Olarak Hemolitik Kriz: Olgu Sunumu
The Accelerated Phase of Chediak-Higashi Syndrome: The Importance of Hematological Evaluation
Chediak-Higashi syndrome is a rare autosomal recessive disease that was first described in 1943 by Bequez-Cesar in 3 siblings that bore the primary clinical features. In 1952 Chediak (a Cuban hematologist) and in 1954 Hi...
Evaluation of Cardiac Parameters in Bone Marrow Transplant Patients: Effect of Pulmonary Artery Pressure on Survival
Objective: Hematopoietic stem cell transplantation (HSCT) is a choice of treatment for malignant and non-malignant diseases. After HSCT, some complications may develop in patients. Cardiac complications are particularly...
Allogeneic Transplantation In Chronic Myeloid Leukemia And The Effect Of Tyrosine Kinase Inhibitors On Survival, A Quasi-Experimental Study
Objective: Tyrosine kinase inhibitors (TKIs) have changed the indications for allogeneic hematopoietic stem cell transplantation (allo-HSCT) in chronic myeloid leukemia (CML). Therefore, we aimed to evaluate the effect o...